World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
42
Citations
8377
World Ranking
5327
National Ranking
451

Clive Loveday publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Clive Loveday sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 129 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Clive Loveday D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Clive Loveday sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 42 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Clive Loveday is affiliated with University College London in the United Kingdom. Their academic profile reflects involvement in research, although specific details about recent papers, co-authors, publication venues, or fields of study are not listed.

There are no recorded papers or publication titles attributed to Clive Loveday at this time. Likewise, no frequent co-authors or collaborative partners have been identified in available data.

The scientist's publication record does not include books nor is there data on publishers associated with their work. Information concerning main research fields, subfields, or specific topics that Clive Loveday has focused on is currently not available.

Similarly, there are no known awards or honors documented for Clive Loveday from the data provided.

Best Publications

  • Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

    Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer

  • Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

    M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

    Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)

    Rob Schuurman;Monique Nijhuis;Remko van Leeuwen;Pauline Schipper

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • The epic Project: Developing National Evidence-based Guidelines for Preventing Healthcare associated Infections

    RJ Pratt;C Pellowe;HP Loveday;N Robinson

  • The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission

    Mari Rose A. Aplasca;David Siegel;Jeffrey S. Mandel;Rosemarie T. Santana-Arciaga

  • Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.

    Helen L. Devereux;Mike Youle;Margaret A. Johnson;Clive Loveday

  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection

    Martin S. Hirsch;Scott M. Hammer;Victoria A. Johnson;Daniel R. Kuritzkes

  • Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

    Amanda Mocroft;Michael Youle;Antonia Moore;Caroline A. Sabin

  • Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients : A randomized controlled comparison with zidovudine monotherapy

    Christine Katlama;Didier Ingrand;Clive Loveday;Nathan Clumeck

  • Hepatitis C virus: evidence for sexual transmission.

    R. S. Tedder;R. J. C. Gilson;M. Briggs;C. Loveday

  • Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.

    A.N. Phillips;D. Dunn;C. Sabin;A. Pozniak

  • Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

    Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  • Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients : A randomized controlled comparison with zidovudine monotherapy

    Schlomo Staszewski;Clive Loveday;Juan J. Picazo;Pierre Dellamonica

  • HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial

    Francoise Brun-Vezinet;Charles Boucher;Clive Loveday;Diane Descamps

  • Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.

    R Schuurman;D Descamps;G J Weverling;S Kaye

  • Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting

    Miller;Anne-Mieke Vandamme;C Loveday;S Staszewski

  • Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations.

    Helen L. Devereux;Vincent C. Emery;Margaret A. Johnson;Clive Loveday

  • Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.

    Alessandro Cozzi-Lepri;Andrew N Phillips;Lidia Ruiz;Bonaventura Clotet

  • The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  • PREVALENCE OF ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS, GONORRHOEA RATES, AND CHANGED SEXUAL BEHAVIOUR IN HOMOSEXUAL MEN IN LONDON

    Unknown

  • HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy

    C Loveday;S Kaye;M Semple;V Ayliffe

  • Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population.

    Amanda Mocroft;Helen Devereux;Sabine Kinloch-de-Loes;Debbie Wilson

Frequent Co-Authors

Andrew N. Phillips
Andrew N. Phillips University College London
Margaret Johnson
Margaret Johnson The Royal Free Hospital
Caroline Sabin
Caroline Sabin University College London
Lidia Ruiz
Lidia Ruiz IrsiCaixa
Richard S. Tedder
Richard S. Tedder King's College London
Charles A. Boucher
Charles A. Boucher Erasmus University Rotterdam
Rob Schuurman
Rob Schuurman Utrecht University
Amanda Mocroft
Amanda Mocroft University College London
Maurizio Zazzi
Maurizio Zazzi University of Siena

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various online degrees and career paths that blend science with practical applications. For instance, roles like a Child Life Specialist are deeply rewarding and understanding how much does a child life specialist make can help students align their goals with financial expectations.

Many students worry about background restrictions when pursuing online education. Fortunately, several online colleges that accept felons provide accessible opportunities, making it possible for diverse individuals to succeed in fields related to microbiology and healthcare.

For those interested in combining patient care with holistic approaches, becoming a Functional Medicine Nurse Practitioner might be an excellent direction. Exploring the functional medicine np salary helps clarify the potential income in this niche nursing role.

Additionally, careers in health information management, such as obtaining a Certified Professional Coder credential, offer robust options for microbiology graduates. Reviewing the cpc certification salary and career paths can guide those looking for a strong blend of clinical knowledge and administrative expertise.

Best Scientists Citing Clive Loveday

Recently Published Articles